awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34147910-0ADB3190-38BD-42E4-9EA6-49874F441F54
Q34147910-0ADB3190-38BD-42E4-9EA6-49874F441F54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34147910-0ADB3190-38BD-42E4-9EA6-49874F441F54
Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.
P2860
Q34147910-0ADB3190-38BD-42E4-9EA6-49874F441F54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34147910-0ADB3190-38BD-42E4-9EA6-49874F441F54
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c5290247ebedc54b0964a9e9d52a4e113b36907e
P2860
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer